AVIR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 14.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $327,852.30

Atea Pharmaceuticals Insider Trading History Chart

Atea Pharmaceuticals Share Price & Price History

^$3.69

▼ -0.01 (-0.27%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

Claim Your Complimentary Bitcoin Reward

From Crypto Swap Profits | Ad

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

Atea Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/1/2024	Andrea Corcoran	Insider	Sell	15,843	$3.84	$60,837.12	670,208
2/1/2024	Jean-Pierre Sommadossi	CEO	Sell	56,910	$3.85	$219,103.50	116,557
2/1/2024	Wayne Foster	CAO	Sell	12,477	$3.84	$47,911.68	20,857
11/14/2022	Franklin M Berger	Director	Sell	16,166	$5.16	$83,416.56	778,353
11/11/2022	Franklin M Berger	Director	Sell	25,500	$5.15	$131,325.00	794,519
12/20/2021	Polly A. Murphy	Director	Buy	12,000	$8.57	$102,840.00

The Gold Grab of the Century

From Colonial Metals | Ad

When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.

That's why we have released our Free Precious Metals Investment Guide.

SEC Filings (Institutional Ownership Changes) for Atea Pharmaceuticals (NASDAQ:AVIR)

86.67% of Atea Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Atea Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/23/2024	BML Capital Management LLC	5,536,710	$22.37M	14.7%	+1.4%	6.578%
2/20/2024	Sunpointe LLC	11,943	$36K	0.0%	N/A	0.014%
2/13/2024	Stonepine Capital Management LLC	839,514	$2.56M	1.1%	-51.2%	1.006%
2/13/2024	Tower Research Capital LLC TRC	30,340	$93K	0.0%	+128.2%	0.036%
2/12/2024	RPO LLC	12,947	$39K	0.1%	N/A	0.016%
2/6/2024	New York Life Investment Management LLC	103,087	$0.31M	0.0%	-3.0%	0.124%
2/2/2024	Marquette Asset Management LLC	47,166	$0.14M	0.0%	+89.7%	0.057%
2/2/2024	Acuitas Investments LLC	171,098	$0.52M	0.3%	+38.6%	0.205%
1/31/2024	Federated Hermes Inc.	595,692	$1.82M	0.0%	-2.2%	0.714%
1/30/2024	BML Capital Management LLC	5,462,079	$16.66M	12.6%	+13.8%	6.546%
1/24/2024	China Universal Asset Management Co. Ltd.	9,653	$29K	0.0%	+351.3%	0.012%
1/12/2024	SG Americas Securities LLC	42,521	$0.13M	0.0%	+23.3%	0.051%
12/18/2023	Gladius Capital Management LP	8,581	$26K	0.0%	+98.2%	0.010%
11/15/2023	GSA Capital Partners LLP	278,286	$0.84M	0.1%	+41.9%	0.334%
11/15/2023	Sectoral Asset Management Inc.	600,461	$1.80M	0.4%	+19.7%	0.720%
11/14/2023	Newtyn Management LLC	400,000	$1.20M	0.3%	+348.4%	0.479%
11/14/2023	Stonepine Capital Management LLC	1,720,000	$5.16M	1.7%	+128.7%	2.061%
11/13/2023	Federated Hermes Inc.	608,786	$1.83M	0.0%	-0.8%	0.730%
11/13/2023	Acadian Asset Management LLC	987,916	$2.96M	0.0%	-0.8%	1.184%
11/13/2023	FMR LLC	6,452,550	$19.36M	0.0%	-24.1%	7.733%
11/8/2023	New York Life Investment Management LLC	106,281	$0.32M	0.0%	-13.6%	0.127%
11/8/2023	Pinnacle Wealth Planning Services Inc.	16,185	$49K	0.0%	N/A	0.019%
11/7/2023	CM Management LLC	275,000	$0.83M	0.9%	+10.0%	0.330%
11/7/2023	Barclays PLC	25,619	$77K	0.0%	+67.8%	0.031%
11/2/2023	Principal Financial Group Inc.	30,392	$91K	0.0%	+17.7%	0.036%
10/23/2023	BML Capital Management LLC	4,800,000	$14.40M	13.2%	+114.6%	5.755%
10/13/2023	SG Americas Securities LLC	34,497	$0.10M	0.0%	N/A	0.041%
10/11/2023	Vontobel Holding Ltd.	600,461	$1.80M	0.0%	+19.7%	0.720%
10/10/2023	Gladius Capital Management LP	8,581	$26K	0.0%	+98.2%	0.010%
9/21/2023	Barclays PLC	15,271	$57K	0.0%	-60.6%	0.018%
8/16/2023	Stonepine Capital Management LLC	752,088	$2.81M	1.0%	+9.9%	0.902%
8/14/2023	Anson Funds Management LP	50,000	$0.19M	0.0%	N/A	0.060%
8/14/2023	Shay Capital LLC	34,635	$0.13M	0.0%	N/A	0.042%
8/14/2023	Prelude Capital Management LLC	24,078	$90K	0.0%	-15.5%	0.029%
8/14/2023	Graham Capital Management L.P.	10,113	$38K	0.0%	N/A	0.012%
8/11/2023	Stonepine Capital Management LLC	752,088	$2.81M	1.1%	+9.9%	0.902%
8/11/2023	Sectoral Asset Management Inc.	501,537	$1.88M	0.3%	+31.7%	0.601%
8/7/2023	Principal Financial Group Inc.	25,818	$97K	0.0%	+16.3%	0.031%
8/7/2023	Acadian Asset Management LLC	996,275	$3.72M	0.0%	-10.3%	1.195%
8/7/2023	New York Life Investment Management LLC	123,025	$0.46M	0.0%	-15.4%	0.148%
8/4/2023	CM Management LLC	250,000	$0.94M	0.9%	-23.1%	0.300%
7/31/2023	Strs Ohio	100,700	$0.38M	0.0%	+5.8%	0.121%
7/24/2023	Vontobel Holding Ltd.	501,537	$1.88M	0.0%	+31.7%	0.601%
7/24/2023	BML Capital Management LLC	2,236,239	$8.36M	7.5%	N/A	2.681%
7/7/2023	Auour Investments LLC	177,000	$0.66M	0.3%	N/A	0.212%
6/1/2023	Prelude Capital Management LLC	28,500	$95K	0.0%	N/A	0.034%
5/15/2023	Stonepine Capital Management LLC	684,508	$2.29M	0.8%	N/A	0.821%
5/12/2023	Sectoral Asset Management Inc.	380,850	$1.28M	0.2%	+35.3%	0.457%
5/12/2023	Martingale Asset Management L P	40,100	$0.13M	0.0%	-81.5%	0.048%
5/11/2023	Acadian Asset Management LLC	1,110,715	$3.72M	0.0%	+27.9%	1.332%
5/8/2023	New York Life Investment Management LLC	145,359	$0.49M	0.0%	+85.0%	0.174%
5/8/2023	CM Management LLC	325,000	$1.09M	1.3%	+18.2%	0.390%
5/8/2023	Federated Hermes Inc.	2,039,056	$6.83M	0.0%	-33.8%	2.445%
5/3/2023	Integrated Wealth Concepts LLC	10,140	$34K	0.0%	N/A	0.012%
5/1/2023	Marquette Asset Management LLC	24,865	$83K	0.0%	N/A	0.030%
5/1/2023	CM Wealth Advisors LLC	19,400	$64K	0.0%	N/A	0.023%
4/28/2023	SG Americas Securities LLC	31,179	$0.10M	0.0%	-20.1%	0.037%
4/27/2023	Strs Ohio	95,200	$0.32M	0.0%	-25.6%	0.114%
4/21/2023	Congress Asset Management Co. MA	197,312	$0.66M	0.0%	+10.9%	0.237%
4/18/2023	ETF Managers Group LLC	26,460	$89K	0.0%	+27.4%	0.032%
4/13/2023	Allspring Global Investments Holdings LLC	23,716	$79K	0.0%	+619.8%	0.028%
4/12/2023	Vontobel Holding Ltd.	380,850	$1.28M	0.0%	+35.3%	0.457%
3/23/2023	ETF Managers Group LLC	20,765	$100K	0.0%	-15.5%	0.025%
2/13/2023	Martingale Asset Management L P	216,285	$1.04M	0.0%	-6.1%	0.260%
2/13/2023	GSA Capital Partners LLP	56,920	$0.27M	0.0%	N/A	0.068%
2/10/2023	Tyrus Capital S.A.M.	1,260,000	$6.06M	13.2%	N/A	1.513%
2/10/2023	New York Life Investment Management LLC	78,563	$0.38M	0.0%	+12.7%	0.094%
2/10/2023	Sectoral Asset Management Inc.	281,403	$1.35M	0.3%	N/A	0.338%
2/10/2023	HRT Financial LP	133,597	$0.64M	0.0%	N/A	0.160%
2/10/2023	Blair William & Co. IL	10,458	$50K	0.0%	N/A	0.013%
2/9/2023	CM Management LLC	275,000	$1.32M	1.6%	+10.0%	0.330%
2/9/2023	First Trust Advisors LP	186,398	$0.90M	0.0%	-6.5%	0.224%
2/9/2023	Denali Advisors LLC	18,000	$87K	0.0%	+309.1%	0.022%
2/8/2023	Swiss National Bank	181,000	$0.87M	0.0%	+2.7%	0.217%
2/8/2023	Russell Investments Group Ltd.	17,008	$82K	0.0%	+277.3%	0.020%
2/2/2023	SG Americas Securities LLC	39,042	$0.19M	0.0%	-50.5%	0.047%
2/2/2023	Gladius Capital Management LP	7,913	$39K	0.0%	+63.2%	0.010%
1/26/2023	Strs Ohio	127,900	$0.62M	0.0%	+40.4%	0.154%
11/15/2022	Martingale Asset Management L P	230,364	$1.31M	0.0%	+57.5%	0.277%
11/15/2022	EcoR1 Capital LLC	6,184,861	$35.19M	1.0%	-2.5%	7.426%
11/15/2022	Federated Hermes Inc.	3,626,818	$20.64M	0.1%	+1.1%	4.354%
11/14/2022	LMR Partners LLP	33,552	$0.19M	0.0%	-51.2%	0.040%
11/14/2022	PDT Partners LLC	68,754	$0.39M	0.1%	N/A	0.083%
11/14/2022	Lazard Asset Management LLC	10,109	$57K	0.0%	-32.4%	0.012%
11/14/2022	MetLife Investment Management LLC	47,234	$0.27M	0.0%	+20.9%	0.057%
11/7/2022	Virtu Financial LLC	30,693	$0.18M	0.0%	N/A	0.037%
11/4/2022	CM Management LLC	250,000	$1.42M	1.6%	+25.0%	0.300%
11/4/2022	Prudential Financial Inc.	294,635	$1.68M	0.0%	-22.3%	0.354%
11/3/2022	Barclays PLC	37,023	$0.21M	0.0%	-21.1%	0.044%
11/2/2022	Los Angeles Capital Management LLC	177,148	$1.01M	0.0%	-12.1%	0.213%
10/31/2022	SG Americas Securities LLC	78,839	$0.45M	0.0%	+20.7%	0.095%
10/27/2022	Strs Ohio	91,100	$0.52M	0.0%	-4.1%	0.109%
10/26/2022	Allspring Global Investments Holdings LLC	11,267	$64K	0.0%	+468.8%	0.014%
10/25/2022	Denali Advisors LLC	4,400	$25K	0.0%	N/A	0.005%
9/16/2022	Federated Hermes Inc.	3,588,131	$25.48M	0.1%	+74.9%	4.310%
8/13/2022	Ronald Blue Trust Inc.	8,700	$63K	0.0%	N/A	0.010%
8/12/2022	Virtus ETF Advisers LLC	15,548	$0.11M	0.0%	-19.6%	0.019%
8/12/2022	FMR LLC	12,539,475	$89.03M	0.0%	-0.3%	15.061%
8/11/2022	Deutsche Bank AG	266,578	$1.89M	0.0%	+8.0%	0.320%
8/9/2022	Swiss National Bank	176,200	$1.25M	0.0%	+382.7%	0.212%

Data available starting January 2016

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antiviral therapeutics for patients with viral infections. Its lead product candidate is AT-527, an oral antiviral candidate that is in Phase 3 SUNRISE-3 clinical trial for the treatment of patients with COVID-19. The company also develops bemnifosbuvir in combination with ruzasvir, which is in Phase 2 clinical trial, for the treatment of hepatitis C virus (HCV); and a protease inhibitor for the treatment of COVID-19. It has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of Ruzasvir, an NS5A inhibitor, for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $3.69

$3.67

$3.75

50 Day Range

MA: $3.97

$3.67

$4.56

52 Week Range

Now: $3.69

$2.77

$5.19

Volume

174,617 shs

Average Volume

423,033 shs

Market Capitalization

$310.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.16

Who are the company insiders with the largest holdings of Atea Pharmaceuticals?: Atea Pharmaceuticals' top insider investors include:
Franklin M Berger (Director)
Andrea Corcoran (Insider)
Jean-Pierre Sommadossi (CEO)
Wayne Foster (CAO)
Learn More about top insider investors at Atea Pharmaceuticals.
Who are the major institutional investors of Atea Pharmaceuticals?: Atea Pharmaceuticals' top institutional investors include:
BML Capital Management LLC — 6.58%
Learn More about top institutional investors of Atea Pharmaceuticals stock.
Which institutional investors are buying Atea Pharmaceuticals stock?: In the last quarter, AVIR stock was acquired by institutional investors including:
BML Capital Management LLC